Previous Close | 159.02 |
Open | 157.97 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 156.86 - 159.00 |
52 Week Range | 112.88 - 160.78 |
Volume | |
Avg. Volume | 10,050 |
Market Cap | 37.735B |
Beta (5Y Monthly) | 0.26 |
PE Ratio (TTM) | 36.00 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.22 (1.40%) |
Ex-Dividend Date | May 10, 2024 |
1y Target Est | N/A |
MINNEAPOLIS, May 10, 2024--Overall readiness levels for Corporate Transparency Act beneficial ownership reporting have notably increased, according to latest Wolters Kluwer poll
WALTHAM, Mass., May 09, 2024--In the highly regulated pharmaceutical industry, implementing the latest technologies to help bring medical breakthroughs to market is of critical importance. That is why Wolters Kluwer Health has collaborated with some of the leading pharmaceutical companies to bring intuitive and easy-to-use workflows to the Ovid® research platform.
NEW YORK, May 09, 2024--Wolters Kluwer, a global leader in information, software, and services for professionals, announces that its OneSumX for ESG and Climate Risk Management solution has been recognized as Best ESG Risk Management Solution at the 2024 ESG Insight Awards.